Miltefosine: What is the Oral Drug for Visceral Leishmaniasis?
•
4 min read
Originally developed as an anticancer agent, miltefosine later emerged as the world's first effective oral drug for leishmaniasis, a neglected tropical disease. This was a significant breakthrough, offering a convenient alternative to traditional parenteral treatments for visceral leishmaniasis (VL). The drug, sold under the brand name Impavido in some regions, has demonstrated high cure rates, though its efficacy can vary by geographic location and parasite species.
